[1] U.S. Food and Drug Administration. Guidance for Industry PAT-A Framework for Innovative Pharmaceutical Development, Manufacturing and Quality Assurance. New Hampshire Avenue: FDA, 2004.
[5] WU Z S, SUI C L, XU B, et al. Journal of Pharmaceutical and Biomedical Analysis, 2013, 77: 16.
[17] LI W L, Xing L H, Fang L M, et al. Pharmaceutical and Biomedical Analysis, 2010, 53: 350.
[18] LI W L, QU H B. Pharmaceutical and Biomedical Analysis, 2010, 52(4): 425.
[23] Jin Y, Wu Z Z, Liu X S, et al. Journal of Pharmaceutical and Biomedical Analysis, 2013, 77: 32.
[32] International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use(ICH). ICH Q8(R2): Pharmaceutical Development. Geneva: ICH, 2009.
[37] Sui C L, Wu Z S, Peng Y F, et al. International Journal of On-Line Engineering, 2003, 44.
[41] Wu Y J, Jin Y, Li Y R, et al. Vibrational Spectroscopy, 2012, 58: 109.
[42] Xiao X, Ma J F, Ge F H, et al. World Scientific, 2014, 7(4): 13500631.
